Literature DB >> 24016742

Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.

Li-Yan Qiu1, Lu Yan, Lu Zhang, Yang-Min Jin, Qing-He Zhao.   

Abstract

The transmembrane transport of drug loaded micelles to intracellular compartment is quite crucial for efficient drug delivery. In the current study, we investigated the cellular internalization and anticancer activity of doxorubicin loaded micelles with folate modified stealthy PEOz corona. Folate-decorated micelles incorporating doxorubicin were characterized for particle size, degree of folate decoration, drug loading content and encapsulation efficiency, morphology, and surface charge. The targeting capability and cell viability were assessed using HeLa, KB, A549 and MCF-7/ADR cell lines. In vitro study clearly illustrated the folate receptor (FR) mediated targeting of FA modified micelles to FR-positive human HeLa, KB and MCF-7/ADR cells, while specific delivery to FR-negative A549 cells was not apparently increased at the same experimental conditions. Cytotoxicity assay showed 60% and 58% decrease in IC50 values for HeLa and KB cells, while only a slight decrease for A549 cells, following treatment with folate modified formulations. The enhanced intracellular delivery of FA modified micelles in MCF-7/ADR cells was also observed. In vivo antitumor tests revealed DOX entrapped FA-PEOz-PCL micelles effectively inhibited the tumor growth and reduced the toxicity to mice compared with free DOX. The current study showed that the targeted nano-vector improved cytotoxicity of DOX and suggested that this novel PEOz endowed stealthy micelle system held great promise in tumor targeted therapy.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antitumor; Boc-OTs; CLSM; CMC; CROP; DOX; Doxorubicin; FA; FR; Folic acid; N-t-Boc-[2-(p-toluenesulfonyloxy)-ethylamine]; PCL; PEOz; PEOz-PCL; Targeting; cationic ring opening polymerization; confocal laser scanning microscopy; critical micelle concentration; doxorubicin; folate receptor; folic acid; poly (2-ethyl-2-oxazoline); poly (ɛ-caprolactone)

Mesh:

Substances:

Year:  2013        PMID: 24016742     DOI: 10.1016/j.ijpharm.2013.08.071

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  Folic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells.

Authors:  Leyuan Xu; Shannon Kittrell; W Andrew Yeudall; Hu Yang
Journal:  Nanomedicine (Lond)       Date:  2016-10-26       Impact factor: 5.307

Review 2.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 3.  Folate-mediated chemotherapy and diagnostics: An updated review and outlook.

Authors:  Leyuan Xu; Qianming Bai; Xin Zhang; Hu Yang
Journal:  J Control Release       Date:  2017-02-22       Impact factor: 9.776

Review 4.  Multifunctional polymeric micelles for delivery of drugs and siRNA.

Authors:  Aditi M Jhaveri; Vladimir P Torchilin
Journal:  Front Pharmacol       Date:  2014-04-25       Impact factor: 5.810

5.  Multifunctional SPIO/DOX-loaded A54 Homing Peptide Functionalized Dextran-g-PLGA Micelles for Tumor Therapy and MR Imaging.

Authors:  Jun-Qing Situ; Xiao-Juan Wang; Xiu-Liang Zhu; Xiao-Ling Xu; Xu-Qi Kang; Jing-Bo Hu; Chen-Ying Lu; Xiao-Ying Ying; Ri-Sheng Yu; Jian You; Yong-Zhong Du
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

6.  Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma.

Authors:  Lu Zhang; Jiafei Lu; Liyan Qiu
Journal:  Int J Nanomedicine       Date:  2016-10-11

7.  Tumor targeting with pH-responsive poly(2-oxazoline)-based nanogels for metronomic doxorubicin treatment.

Authors:  Doerte Hoelzer; Meike N Leiske; Matthias Hartlieb; Tanja Bus; David Pretzel; Stephanie Hoeppener; Kristian Kempe; René Thierbach; Ulrich S Schubert
Journal:  Oncotarget       Date:  2018-04-27

8.  MMP-13 enzyme and pH responsive theranostic nanoplatform for osteoarthritis.

Authors:  Qiumei Lan; Rongbin Lu; Haimin Chen; Yunfen Pang; Feng Xiong; Chong Shen; Zainen Qin; Li Zheng; Guojie Xu; Jinmin Zhao
Journal:  J Nanobiotechnology       Date:  2020-08-27       Impact factor: 10.435

Review 9.  Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies.

Authors:  Brandon Bumbaca; Wei Li
Journal:  Acta Pharm Sin B       Date:  2018-04-30       Impact factor: 11.413

10.  Preparation of β-CD-DPPE-Dox Nanomedicine and Its' Application as the Anticancer and Antitumor Drug.

Authors:  Miaomiao Yan; Anran Cai; Jing Li; Meixiu Xin; Mingying Liu; Chunhua Wang; Guangcheng Wei
Journal:  Sci Rep       Date:  2019-09-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.